This provides strong evidence that IGF2BP1 may further enhance miRNA-dependent regulation in ATC, since the main, conserved role of IGF2BP1 in cancer is the enhancement of pro-oncogenic factors by impairing their miRNA-directed inhibition [11,12,13,51]. This evidence concerns the gene IGF2BP1 and cancer.